ID

14295

Description

Cell Biology of Steroid Resistant Asthma; ODM derived from: https://clinicaltrials.gov/show/NCT00361920

Lien

https://clinicaltrials.gov/show/NCT00361920

Mots-clés

  1. 07/04/2016 07/04/2016 -
Détendeur de droits

CC BY-NC 3.0

Téléchargé le

7 avril 2016

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY-NC 3.0

Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Eligibility Asthma NCT00361920

Eligibility Asthma NCT00361920

  1. StudyEvent: Eligibility
    1. Eligibility Asthma NCT00361920
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
1. will meet american thoracic society criteria for asthma
Description

asthma

Type de données

boolean

Alias
UMLS CUI [1]
C0004096
2. pulmonary function tests consistent with asthma. this includes a baseline fev1 < 80% predicted as well as a 12% improvement in fev1 following up to 4 puffs of albuterol.
Description

fev1

Type de données

boolean

Alias
UMLS CUI [1]
C0748133
UMLS CUI [2]
C0001927
3. subjects must be 12 to 65 years old.
Description

age

Type de données

boolean

Alias
UMLS CUI [1]
C0001779
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
1. viral infection within four weeks of the starting date.
Description

viral infection

Type de données

boolean

Alias
UMLS CUI [1,1]
C0009450
UMLS CUI [1,2]
C0040223
2. abnormal hepatic function.
Description

hepatic function

Type de données

boolean

Alias
UMLS CUI [1]
C0232741
3. history of copd
Description

copd

Type de données

boolean

Alias
UMLS CUI [1]
C0024117
4. pregnancy.
Description

pregnancy

Type de données

boolean

Alias
UMLS CUI [1]
C0032961
5. history of smoking.
Description

history of smoking

Type de données

boolean

Alias
UMLS CUI [1]
C1519384
6. anemia (hemoglobin less than 12 gm %)
Description

anemia

Type de données

boolean

Alias
UMLS CUI [1]
C0002871
7. concurrent therapy with anticonvulsants, erythromycin, rifampin and any systemic asthma medication including singular®, xolair® or oral prednisone.
Description

anticonvulsants, erythromycin, rifampin and any systemic asthma medication including singular®, xolair® or oral prednisone

Type de données

boolean

Alias
UMLS CUI [1]
C0003286
UMLS CUI [2]
C0014806
UMLS CUI [3]
C0035608
UMLS CUI [4,1]
C0013227
UMLS CUI [4,2]
C0004096
UMLS CUI [4,3]
C0205373
UMLS CUI [5]
C1174773
UMLS CUI [6]
C3216040
8. greater than 500 mcg per day of inhaled corticosteroids
Description

inhaled corticosteroids

Type de données

boolean

Alias
UMLS CUI [1]
C2065041
9. suspected non-compliance with medical care.
Description

non-compliance with medical care

Type de données

boolean

Alias
UMLS CUI [1]
C1321605
10. abnormal prednisone pharmacokinetics (applies to phase 2 of trial)
Description

abnormal prednisone pharmacokinetics

Type de données

boolean

Alias
UMLS CUI [1,1]
C0032952
UMLS CUI [1,2]
C0031327
11. patients with severe medical conditions that in the view of the investigator prohibits participation in the study (specify as required)
Description

comorbidity limiting participation

Type de données

boolean

Alias
UMLS CUI [1,1]
C1321605
UMLS CUI [1,2]
C0439801
UMLS CUI [1,3]
C0009488
12. use of any investigational agent in the last 30 days
Description

investigational agent

Type de données

boolean

Alias
UMLS CUI [1]
C1875319

Similar models

Eligibility Asthma NCT00361920

  1. StudyEvent: Eligibility
    1. Eligibility Asthma NCT00361920
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
C1512693 (UMLS CUI)
asthma
Item
1. will meet american thoracic society criteria for asthma
boolean
C0004096 (UMLS CUI [1])
fev1
Item
2. pulmonary function tests consistent with asthma. this includes a baseline fev1 < 80% predicted as well as a 12% improvement in fev1 following up to 4 puffs of albuterol.
boolean
C0748133 (UMLS CUI [1])
C0001927 (UMLS CUI [2])
age
Item
3. subjects must be 12 to 65 years old.
boolean
C0001779 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
viral infection
Item
1. viral infection within four weeks of the starting date.
boolean
C0009450 (UMLS CUI [1,1])
C0040223 (UMLS CUI [1,2])
hepatic function
Item
2. abnormal hepatic function.
boolean
C0232741 (UMLS CUI [1])
copd
Item
3. history of copd
boolean
C0024117 (UMLS CUI [1])
pregnancy
Item
4. pregnancy.
boolean
C0032961 (UMLS CUI [1])
history of smoking
Item
5. history of smoking.
boolean
C1519384 (UMLS CUI [1])
anemia
Item
6. anemia (hemoglobin less than 12 gm %)
boolean
C0002871 (UMLS CUI [1])
anticonvulsants, erythromycin, rifampin and any systemic asthma medication including singular®, xolair® or oral prednisone
Item
7. concurrent therapy with anticonvulsants, erythromycin, rifampin and any systemic asthma medication including singular®, xolair® or oral prednisone.
boolean
C0003286 (UMLS CUI [1])
C0014806 (UMLS CUI [2])
C0035608 (UMLS CUI [3])
C0013227 (UMLS CUI [4,1])
C0004096 (UMLS CUI [4,2])
C0205373 (UMLS CUI [4,3])
C1174773 (UMLS CUI [5])
C3216040 (UMLS CUI [6])
inhaled corticosteroids
Item
8. greater than 500 mcg per day of inhaled corticosteroids
boolean
C2065041 (UMLS CUI [1])
non-compliance with medical care
Item
9. suspected non-compliance with medical care.
boolean
C1321605 (UMLS CUI [1])
abnormal prednisone pharmacokinetics
Item
10. abnormal prednisone pharmacokinetics (applies to phase 2 of trial)
boolean
C0032952 (UMLS CUI [1,1])
C0031327 (UMLS CUI [1,2])
comorbidity limiting participation
Item
11. patients with severe medical conditions that in the view of the investigator prohibits participation in the study (specify as required)
boolean
C1321605 (UMLS CUI [1,1])
C0439801 (UMLS CUI [1,2])
C0009488 (UMLS CUI [1,3])
investigational agent
Item
12. use of any investigational agent in the last 30 days
boolean
C1875319 (UMLS CUI [1])

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial